NCT04055337

Flap Sliding to Treat Post-LASIK Striae

Completed NA Last updated 13 August 2019

What this trial tests

NA trial testing Flap sliding in LASIK Complication Management in 14 participants. Completed in 30 June 2018.

Timeline

1 January 2018

Primary endpoint
30 June 2018

30 June 2018

Quick facts

Lead sponsor	Assiut University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	14
Start date	1 January 2018
Primary completion	30 June 2018
Estimated completion	30 June 2018
Sites	1 location across Egypt

Drugs / interventions tested

• Flap sliding

Conditions studied

• LASIK Complication Management — all drugs for LASIK Complication Management →

Sponsor

Assiut University

Who can join

Adults 20 to 40, any sex, with LASIK Complication Management. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study assessed the efficacy and safety of a simple, noninvasive "flap sliding" technique for managing flap striae following laser in situ keratomileusis (LASIK). Included eyes underwent flap sliding 1-2 days after surgery, which involved using a cellulose sponge to gently slide the flap perpendicular to the striae. The flap was not lifted during the procedure. Thirteen of 14 eyes were successfully managed with flap sliding. Uncorrected distance visual acuity (DVA) improved in all patients 1 day after flap sliding, with 11 eyes having a corrected DVA of 20/25 or better. Complications following flap sliding occurred in 2 eyes. We believe that our study makes a significant contribution to the literature because it demonstrates a simple, noninvasive technique for managing flap striae that develop during early post-LASIK epithelial healing.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Flap Sliding Technique for Managing Flap Striae following Laser In Situ Keratomileusis.
   Abdelazeem K, Nassr MA, Abdelmotaal H, Wasfi E, et al · · 2020 · cited 3× · PMID 32185074 · DOI 10.1155/2020/5614327